Coming Soon
Understanding Catatonia, Catatonic Disorder, and Catatonic Schizophrenia: This resource provides information on diagnosing and documenting catatonia, including clinical features, diagnostic criteria, and medical coding for healthcare professionals. Learn about the subtypes and associated conditions of catatonia for accurate clinical documentation and improved patient care. Explore resources related to the assessment and management of catatonic symptoms and their relationship to other mental health disorders.
Also known as
Schizophrenia, schizotypal and delusional disorders
Includes catatonic schizophrenia and other related psychotic disorders.
Other mental disorders due to brain damage and dysfunction and to physical disease
Catatonia may arise from underlying medical conditions affecting the brain.
Symptoms and signs involving appearance and behaviour
Includes abnormal behaviour such as stupor and excitement, potentially related to catatonia.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is catatonia associated with another mental disorder?
When to use each related code
| Description |
|---|
| Marked psychomotor disturbance. |
| Delusions, hallucinations, disorganized speech. |
| Brief psychosis lasting less than one month. |
Coding catatonia without specifying underlying cause (e.g., medical condition vs. schizophrenia) leads to inaccurate severity and reimbursement.
Differentiating true catatonia from factitious disorder or malingering requires thorough documentation of clinical findings for accurate coding and audit defense.
Failing to code coexisting conditions like depression, anxiety, or substance use alongside catatonia impacts risk adjustment and quality reporting.
Q: How can I differentiate between catatonia due to a medical condition vs. catatonia associated with psychiatric disorders like schizophrenia in my differential diagnosis?
A: Differentiating between catatonia due to a medical condition (like infections, metabolic disturbances, or neurological disorders) and catatonia associated with psychiatric disorders like schizophrenia requires a thorough assessment. Key considerations include a detailed medical history, physical examination, and laboratory testing to rule out underlying medical causes. Neurological examination findings, such as the presence of primitive reflexes or other neurological soft signs, may suggest an organic etiology. Observe for fluctuations in the catatonic symptoms, which can be more characteristic of medical causes. Consider implementing the Bush-Francis Catatonia Rating Scale (BFCRS) to objectively assess the severity and monitor changes in catatonic symptoms. If an underlying medical condition is suspected, treat the underlying condition first. Explore how managing the medical issue impacts the catatonic symptoms. If catatonia persists despite treating the medical condition, or if no underlying medical cause is found, evaluate for psychiatric causes, particularly mood disorders and schizophrenia. Learn more about the diagnostic criteria for catatonia specifier as defined in DSM-5-TR.
Q: What are the best evidence-based treatment options for catatonia, including both pharmacological and non-pharmacological approaches?
A: Benzodiazepines, particularly lorazepam, are considered first-line pharmacological treatment for catatonia. Electroconvulsive therapy (ECT) is a highly effective treatment for catatonia, particularly when benzodiazepines are ineffective or when rapid response is crucial, such as in cases with malignant catatonia. Non-pharmacological approaches, such as supportive care and minimizing environmental stimulation, are also important components of treatment. Consider implementing a structured environment and ensuring patient safety during the acute phase. Explore how incorporating occupational therapy and physical therapy can help with functional recovery. For patients with catatonia secondary to a general medical condition, the priority is to identify and treat the underlying cause. Learn more about the efficacy and safety profiles of different treatment modalities for catatonia.
Patient presents with symptoms consistent with a diagnosis of Catatonia, also known as Catatonic Disorder or Catatonic Schizophrenia. Clinical presentation includes prominent psychomotor disturbances, manifesting as immobility (stupor, catalepsy), excessive motor activity (stereotypies, mannerisms, agitation), negativism, mutism, peculiarities of voluntary movement (posturing, grimacing, waxy flexibility), and echolalia or echopraxia. Differential diagnosis considerations include neuroleptic malignant syndrome, encephalitis, and other organic medical conditions. Assessment included a thorough neurological examination, mental status examination, and review of medical history. Current medications were reviewed for potential drug-induced catatonia. Laboratory tests were ordered to rule out metabolic and infectious etiologies. The patient meets the DSM-5 criteria for Catatonia, exhibiting three or more characteristic symptoms. Severity of catatonic features impacts functional capacity, including activities of daily living and social interaction. Treatment plan includes consideration of benzodiazepines (lorazepam challenge test) and electroconvulsive therapy (ECT) if pharmacotherapy is ineffective. Prognosis, patient education regarding catatonia symptoms and treatment options, and potential complications were discussed. Follow-up appointments are scheduled to monitor treatment response and adjust management as needed. ICD-10 coding for catatonia will be determined based on the underlying diagnosis (e.g., F20.2 for Catatonic Schizophrenia). Medical billing will reflect the complexity of the evaluation and management services provided. Ongoing monitoring and documentation of catatonic signs and symptoms will be crucial for optimizing patient outcomes and informing treatment decisions.